A detailed history of Optiver Holding B.V. transactions in Astrazeneca PLC stock. As of the latest transaction made, Optiver Holding B.V. holds 295,625 shares of AZN stock, worth $22.2 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
295,625
Holding current value
$22.2 Million
% of portfolio
0.45%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $19.8 Million - $23.9 Million
295,625 New
295,625 $23.1 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $26 Million - $29.1 Million
420,123 Added 63.57%
1,080,990 $72.8 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $21.9 Million - $24.2 Million
338,209 Added 104.82%
660,867 $44.8 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $33.1 Million - $35.9 Million
-473,163 Reduced 59.46%
322,658 $23.1 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $26.4 Million - $29.9 Million
417,354 Added 110.27%
795,821 $55.2 Million
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $1.27 Million - $1.65 Million
-23,428 Reduced 5.83%
378,467 $25.7 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $21.3 Million - $54.6 Million
401,895 New
401,895 $22.2 Million
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $4.79 Million - $5.75 Million
-80,849 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $43.1 Million - $51.9 Million
-773,226 Reduced 90.53%
80,849 $5.36 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $46.1 Million - $54.5 Million
854,075 New
854,075 $49.7 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $36.9 Million - $45.8 Million
-761,613 Closed
0 $0
Q1 2021

May 20, 2021

SELL
$47.16 - $54.44 $552 Million - $637 Million
-11,702,465 Reduced 93.89%
761,613 $37.9 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $588 Million - $679 Million
12,464,078 New
12,464,078 $626 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.